Home » House Members Join Probe in Allergan-Mohawk Patent Deal
House Members Join Probe in Allergan-Mohawk Patent Deal
October 5, 2017
Republicans and Democrats on the House Oversight Committee pressed Allergan for an explanation of its decision to transfer patents for its lucrative dry-eye drug Restasis to a Mohawk tribe to protect them from challenges by would-be generic competitors.
The “unconventional maneuver” by Allergan “may impair competition across the pharmaceutical industry and ultimately dissuade companies from pursuing less-costly generic alternatives to brand drugs,” the letter said.
Signed by Chairman Trey Gowdy (R-S.C.), Ranking Member Elijah Cummings (D-Md.), and Reps. Dennis Ross (R-Fla.) and Peter Welch (D-Vt.), the letter asks for documents and communications related to the transaction.
Upcoming Events
-
21Oct